InvestorsHub Logo
Followers 9
Posts 381
Boards Moderated 0
Alias Born 06/27/2015

Re: None

Tuesday, 11/22/2016 12:02:46 AM

Tuesday, November 22, 2016 12:02:46 AM

Post# of 2104
Were they talking about GILD's simtuzumab when they said in the stifel presentation that only 2 is left in the LC nash space. What is the other still in play besides emricasan. Tia.